mRNA and Oligonucleotide Therapeutics

The European pharmaceutical industry is rapidly advancing with innovative approaches in mRNA and Oligonucleotide Therapeutics, driving new solutions for rare diseases, cancer, and infectious conditions. With strong R&D hubs across…